Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

被引：0
|
作者：
Abdoul Habib Beavogui
Alioune Camara
Alexandre Delamou
Mamadou Saliou Diallo
Abdoulaye Doumbouya
Karifa Kourouma
Patrice Bouedouno
Timothée Guilavogui
Samaly dos Santos Souza
Julia Kelley
Eldin Talundzic
Aissata Fofana
Mateusz M. Plucinski
机构：
[1] Centre National de Formation et de Recherche en Santé Rurale de Maferinyah,Department of Medical Sciences
[2] Gamal Abdel Nasser University,Centre d’Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA
[3] Gamal Abdel Nasser University,PCMT)
[4] Gamal Abdel Nasser University,Department of Public Health
[5] National Malaria Control Programme,Malaria Branch
[6] Direction of Epidemiology,Atlanta Research and Education Foundation and Malaria Branch
[7] Ministry of Health,Malaria Branch and U.S. President’s Malaria Initiative
[8] Centers for Disease Control and Prevention,undefined
[9] Centers for Disease Control and Prevention,undefined
[10] RTI International,undefined
[11] Centers for Disease Control and Prevention,undefined
来源：
Malaria Journal | / 19卷
关键词：
Efficacy; Artesunate–amodiaquine; Artemether–lumefantrine; Molecular makers; Guinea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
    Uwimana, Aline
    Penkunas, Michael J.
    Nisingizwe, Marie Paul
    Warsame, Marian
    Umulisa, Noella
    Uyizeye, Didier
    Musanabaganwa, Clarisse
    Munyaneza, Tharcisse
    Ntagwabira, Edouard
    Hakizimana, Dieudonne
    Muvunyi, Claude Mambo
    Kayobotsi, Claver
    Kabera, Michee
    Murindahabi, Monique
    Mbituyumuremyi, Aimable
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 (06) : 312 - 319
  • [32] Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
    Sondo, Paul
    Derra, Karim
    Diallo-Nakanabo, Seydou
    Tarnagda, Zekiba
    Zampa, Odile
    Kazienga, Adama
    Valea, Innocent
    Sorgho, Hermann
    Owusu-Dabo, Ellis
    Ouedraogo, Jean-Bosco
    Guiguemde, Tinga Robert
    Tinto, Halidou
    MALARIA JOURNAL, 2015, 14
  • [33] Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial
    Obonyo, Charles O.
    Muok, Erick M. O.
    Mwinzi, Pauline N. M.
    LANCET INFECTIOUS DISEASES, 2010, 10 (09): : 603 - 611
  • [34] Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-umefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial (vol 22, pg 867, 2022)
    Peto, T. J.
    Tripura, R.
    Callery, J. J.
    LANCET INFECTIOUS DISEASES, 2022, 22 (05): : E128 - E128
  • [35] Early integration of palliative care versus standard cardiac care for patients with heart failure (EPCHF): a multicentre, parallel, two-arm, open-label, randomised controlled trial
    Balata, Mahmoud
    Radbruch, Lukas
    Hesse, Michaela
    Westenfeld, Ralf
    Neukirchen, Martin
    Pfister, Roman
    Batzler, Yann-Nicolas
    Oeztuerk, Can
    Kavsur, Refik
    Tiyerili, Vedat
    Weltermann, Birgitta
    Poelsler, Robert
    Standl, Thomas
    Nickenig, Georg
    Becher, Marc Ulrich
    LANCET HEALTHY LONGEVITY, 2024, 5 (10):
  • [36] Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Cote d'Ivoire
    Toure, Offianan A.
    Assi, Serge B.
    N'Guessan, Tiacoh L.
    Adji, Gbessi E.
    Ako, Aristide B.
    Brou, Marie J.
    Ehouman, Marie F.
    Gnamien, Laeticia A.
    Coulibaly, M'Lanhoro A. A.
    Coulibaly, Baba
    Beourou, Sylvain
    Bassinka, Issiaka
    Soumahoro, Adama
    Kadjo, Florence
    Tano, Mea A.
    MALARIA JOURNAL, 2014, 13
  • [37] Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
    Chris Ebong
    Asadu Sserwanga
    Jane Frances Namuganga
    James Kapisi
    Arthur Mpimbaza
    Samuel Gonahasa
    Victor Asua
    Sam Gudoi
    Ruth Kigozi
    James Tibenderana
    John Bosco Bwanika
    Agaba Bosco
    Denis Rubahika
    Daniel Kyabayinze
    Jimmy Opigo
    Damian Rutazana
    Gloria Sebikaari
    Kassahun Belay
    Mame Niang
    Eric S. Halsey
    Leah F. Moriarty
    Naomi W. Lucchi
    Samaly S. Svigel Souza
    Sam L. Nsobya
    Moses R. Kamya
    Adoke Yeka
    Malaria Journal, 20
  • [38] Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
    Ebong, Chris
    Sserwanga, Asadu
    Namuganga, Jane Frances
    Kapisi, James
    Mpimbaza, Arthur
    Gonahasa, Samuel
    Asua, Victor
    Gudoi, Sam
    Kigozi, Ruth
    Tibenderana, James
    Bwanika, John Bosco
    Bosco, Agaba
    Rubahika, Denis
    Kyabayinze, Daniel
    Opigo, Jimmy
    Rutazana, Damian
    Sebikaari, Gloria
    Belay, Kassahun
    Niang, Mame
    Halsey, Eric S.
    Moriarty, Leah F.
    Lucchi, Naomi W.
    Souza, Samaly S. Svigel
    Nsobya, Sam L.
    Kamya, Moses R.
    Yeka, Adoke
    MALARIA JOURNAL, 2021, 20 (01)
  • [39] Efficacy and safety of pyronaridine–artesunate versus artemether–lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial
    Catherine O. Falade
    Adebola E. Orimadegun
    Fiyinfoluwa I. Olusola
    Obaro S. Michael
    Oluwafunmibi E. Anjorin
    Roland I. Funwei
    Aduragbenro D. Adedapo
    Abiola L. Olusanya
    Bose E. Orimadegun
    Olugbenga A. Mokuolu
    Malaria Journal, 22
  • [40] Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study
    Klopstock, Thomas
    Tricta, Fernando
    Neumayr, Lynne
    Karin, Ivan
    Zorzi, Giovanna
    Fradette, Caroline
    Kmiec, Tomasz
    Buchner, Boriana
    Steele, Hannah E.
    Horvath, Rita
    Chinnery, Patrick F.
    Basu, Anna
    Kupper, Clemens
    Neuhofer, Christiane
    Kalman, Bernadette
    Dusek, Petr
    Yapici, Zuhal
    Wilson, Ian
    Zhao, Feng
    Zibordi, Federica
    Nardocci, Nardo
    Aguilar, Christine
    Hayflick, Susan J.
    Spino, Michael
    Blamire, Andrew M.
    Hogarth, Penelope
    Vichinsky, Elliott
    LANCET NEUROLOGY, 2019, 18 (07): : 631 - 642
12345